4 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 24866893 | The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells. | 2014 | 1 |
2 | 14999148 | Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER -2/ neu -overexpressing human breast cancer cells to docetaxel (taxotere). | 2004 Mar | 5 |
3 | 15235125 | Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. | 2004 Jul 20 | 1 |
4 | 15390078 | Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. | 2004 Nov | 1 |